🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12475+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12475 recruiting trials

NARecruitingNCT05881005

NAC- NAFLD and Cushing

👨‍⚕️ Claire BRIET, University Hospital of Anger📍 6 sites📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05920798

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

👨‍⚕️ Matthew S. Block, MD, PhD, Mayo Clinic in Rochester📍 3 sites📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05957367

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

👨‍⚕️ Clinical Team, Deciphera Pharmaceuticals, LLC📍 22 sites📅 Started Sep 2023View details ↗
Phase 3Enrolling by InvitationNCT05967351

A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

🏥 Sarepta Therapeutics, Inc.📍 20 sites📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05636618

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors

🏥 Perspective Therapeutics📍 17 sites📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT06056752

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

👨‍⚕️ Xiaoyu Zhu, Ph.D, Director of Hematology Department, Anhui Provincial Hospital📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT06066333

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

👨‍⚕️ Nitya Raj, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Sep 2023View details ↗
RecruitingNCT06051045

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients

🏥 Karolinska University Hospital📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06302777

MAIN-IMAGE Registry

🏥 Goethe University📍 2 sites📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05890352

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

👨‍⚕️ Jennifer E Amengual, SWOG Cancer Research Network📍 104 sites📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT05937295

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition

👨‍⚕️ Salih, Prof. Dr., CCU Translational Immunology📍 1 site📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT05936359

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

👨‍⚕️ Incyte Medical Monitor, Incyte Corporation📍 29 sites📅 Started Sep 2023View details ↗
Phase 4RecruitingNCT05743400

Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

🏥 Hospices Civils de Lyon📍 2 sites📅 Started Sep 2023View details ↗
RecruitingNCT05968053

Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)

👨‍⚕️ Runting Li, MD, Beijing Tiantan Hospital📍 1 site📅 Started Sep 2023View details ↗
NAEnrolling by InvitationNCT06133530

Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica

👨‍⚕️ Martina Heer, PhD, IU International University of Applied Sciences, Erfurt, Germany📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06040567

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

👨‍⚕️ Britt S Pedersen, Rigshospitalet, University of Copenhagen📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05989958

The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

👨‍⚕️ YU Chen, MD, Beijing YouAn Hospital📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT06058091

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

👨‍⚕️ Jing Wang, Jiangsu Renocell Biotech Company📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT06058988

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

👨‍⚕️ Nelson Moss, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05664815

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

👨‍⚕️ Aurélien LOUVRIER, MD, PhD, CHU de Besançon📍 5 sites📅 Started Sep 2023View details ↗
← PreviousPage 374 of 624Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →